Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 12 Jun 2024

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort

in Pharmacoepidemiology

Nathan Vidal
Paul Roux
Mathieu Urbach
Cristobal Belmonte
Laurent Boyer
Delphine Capdevielle
Julie Clauss-Kobayashi
Thierry D’Amato
Romane Dassing
Caroline Dubertret

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403093

1,444 views

Original Research

Published on 07 Jun 2024

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Liyuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397029

6,911 views
5 citations

Data Report

Published on 06 Jun 2024

The last 3 decade of vaccination coverage in the Balkan and Eastern Europe countries with reference to the impact of the COVID-19 pandemic

in Pharmacoepidemiology

Milos Stepovic
Viktorija Dragojevic Simic
Ivana Zivanovic Macuzic
Radoje Simic
Stefan Vekic
Marija Sekulic
Snezana Radovanovic
Milena Maricic
Marija Sorak
Vesna Suljagic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1278771

5,002 views
2 citations

Original Research

Published on 05 Jun 2024

Comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events—a real-world longitudinal inception cohort study

in Pharmacoepidemiology

Xuechun Li
Maarten J. Bijlsma
Stijn de Vos
Jens H. J. Bos
Sumaira Mubarik
Catharina C. M. Schuiling-Veninga
Eelko Hak

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357567

1,490 views
1 citation

Original Research

Published on 05 Jun 2024

Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Huqun Li
Chongshu Wang
Cuilian Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385036

3,801 views
2 citations

Original Research

Published on 31 May 2024

Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients

in Pharmacoepidemiology

Xiao-Na Ma
Mei-Feng Shi
Shiow-Ing Wang
Wei Feng
Shu-Lin Chen
Xiao-Qin Zhong
Qing-Ping Liu
James Cheng-Chung Wei
Chang-Song Lin
Qiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370661

2,429 views
2 citations

Original Research

Published on 30 May 2024

A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database

in Pharmacoepidemiology

Yuan Liu
Hao Li
Cheng Hu
Li Tan
Ping Yin
Zhihao Li
Shuangshan Zhou
Li Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368244

2,398 views
1 citation

Original Research

Published on 27 May 2024

Comparison of the safety profiles for pirfenidone and nintedanib: a disproportionality analysis of the US food and drug administration adverse event reporting system

in Pharmacoepidemiology

Xiangyu Sun
Huaguang Wang
Xi Zhan
Yuanyuan Yan
Kun Chen
Zhuoling An
Hong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1256649

6,499 views
1 citation

Original Research

Published on 23 May 2024

Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis

in Pharmacoepidemiology

Yujia Li
Huilin Tang
Yi Guo
Hui Shao
Stephen E. Kimmel
Jiang Bian
Desmond A. Schatz
Jingchuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379251

1,752 views
2 citations

Original Research

Published on 23 May 2024

Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Xiping Yang
Yan Yan
Suyao Liu
Zhiqing Wang
Xia Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376494

3,406 views

Original Research

Published on 22 May 2024

COVID-19 vaccination-related tinnitus is associated with pre-vaccination metabolic disorders

in Pharmacoepidemiology

Weihua Wang
Anusha Yellamsetty
Robert M. Edmonds
Shaun R. Barcavage
Shaowen Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374320

25,304 views
1 citation

Original Research

Published on 13 May 2024

Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database

in Pharmacoepidemiology

Dan Li
Yuan Zhang
Jia Qi Ni
Juan Zhu
Wen Ting Lu
Ya Lin Chen
Lei Cheng
Yu Qi Wang
Qian Jiang Li
Jie Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372401

3,425 views
1 citation

Original Research

Published on 09 May 2024

Assessing the safety of bedaquiline: insight from adverse event reporting system analysis

in Pharmacoepidemiology

Jiaqiang Wu
Hong Pan
Li Shen
Mingyi Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382441

2,743 views
2 citations

Original Research

Published on 09 May 2024

Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database

in Pharmacoepidemiology

Dan Zhao
Wangxin Zhang
Yan Liu
Zhaojun Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389814

3,096 views
3 citations

Original Research

Published on 29 Apr 2024

Association between atorvastatin and erectile dysfunction: a comprehensive analysis incorporating real-world pharmacovigilance and Mendelian randomization

in Pharmacoepidemiology

Kaiqin Chen
Hesen Huang
Yongtai Chen
Weizhen He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382924

23,209 views
2 citations

Original Research

Published on 24 Apr 2024

Assessment of antimicrobial prescribing patterns, guidelines compliance, and appropriateness of antimicrobial prescribing in surgical-practice units: point prevalence survey in Malaysian teaching hospitals

in Pharmacoepidemiology

Nurul Adilla Hayat Jamaluddin
Petrick Periyasamy
Chee Lan Lau
Sasheela Ponnampalavanar
Pauline Siew Mei Lai
Ly Sia Loong
Tg Mohd Ikhwan Tg Abu Bakar Sidik
Ramliza Ramli
Toh Leong Tan
Najma Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381843

3,472 views
2 citations